Obesity and cardiovascular disease: is body structure a factor?
Related Experiment Videos
1Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.
Insights
Abdominal obesity increases cardiovascular risks. Weight loss can significantly improve these health risks associated with excess abdominal fat.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Obesity is a major risk factor for cardiovascular disease.
- Abdominal obesity, particularly visceral fat, is linked to adverse health outcomes.
- Associated conditions include atherogenic lipid profiles and insulin resistance.
Purpose of the Study:
- To highlight the link between abdominal obesity and cardiovascular risks.
- To discuss the metabolic and hemostatic abnormalities associated with visceral fat.
- To emphasize the benefits of weight loss in mitigating these risks.
Main Methods:
- Review of existing literature on obesity and cardiovascular health.
- Analysis of the relationship between fat distribution and metabolic markers.
- Assessment of the impact of weight reduction on cardiovascular risk factors.
Main Results:
- Abdominal obesity is strongly correlated with increased cardiovascular morbidity and mortality.
- Visceral fat accumulation is associated with atherogenic lipid profiles, insulin resistance, and hemostatic abnormalities.
- Weight loss interventions demonstrate improvements in cardiovascular risk factors.
Conclusions:
- Abdominal obesity poses a significant threat to cardiovascular health.
- Targeting visceral fat through weight loss is crucial for reducing atherothrombotic risk.
- Managing obesity is key to preventing cardiovascular complications.
Abstract:
Obesity is associated with increased cardiovascular morbidity and mortality. Individuals who predominantly store fat abdominally (particularly in the visceral area), more often present with an atherogenic lipid profile and are more frequently characterized by hemostatic, metabolic and anatomical abnormalities compatible with insulin resistance and increased atherothrombotic risk. Weight loss improves many of the cardiovascular risk factors associated with abdominal obesity.
Related Concept Videos
Obesity
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Drug Dosing: Obese Patients